PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 21 filers reported holding PHARVARIS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,472,000 | -67.8% | 1,104,552 | -7.2% | 0.17% | -68.9% |
| Q2 2022 | $26,307,000 | -8.0% | 1,190,343 | -24.5% | 0.54% | -15.0% |
| Q1 2022 | $28,600,000 | +25.7% | 1,577,078 | -0.3% | 0.64% | +34.0% |
| Q4 2021 | $22,755,000 | -20.2% | 1,581,331 | -1.7% | 0.48% | -14.4% |
| Q3 2021 | $28,518,000 | +48.2% | 1,608,471 | +55.7% | 0.56% | +62.9% |
| Q2 2021 | $19,240,000 | -33.4% | 1,032,757 | 0.0% | 0.34% | -43.7% |
| Q1 2021 | $28,897,000 | – | 1,032,757 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,261,926 | $57,834,000 | 8.52% |
| venBio Partners LLC | 2,303,310 | $40,838,000 | 4.07% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $56,392,000 | 3.50% |
| Foresite Capital Management V, LLC | 364,142 | $6,456,000 | 2.01% |
| VR Adviser, LLC | 552,882 | $9,803,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,608,471 | $28,518,000 | 0.56% |
| Cormorant Asset Management, LP | 689,731 | $12,229,000 | 0.50% |
| Novo Holdings A/S | 418,943 | $7,428,000 | 0.38% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $42,909,000 | 0.25% |
| DAFNA Capital Management LLC | 35,074 | $622,000 | 0.16% |